Favrod-Coune Thierry, Cordonier Isabelle, Ortiz de Zarate Griselda, Lidsky Déborah
Unité des dépendances, Service de médecine de premier recours, Hôpitaux universitaires de Genève, 1211 Genève 14.
Clinique de Crans-Montana, Médecine interne de réhabilitation, Hôpitaux universitaires de Genève, 1211 Genève 14.
Rev Med Suisse. 2025 Jan 22;21(902):97-101. doi: 10.53738/REVMED.2025.21.902.97.
The use of psychoactive substances affects more men than women, with a prevalence that is 1.3 to 2 times higher, except for the use of sedatives. Men are also more affected by accidents, injuries, and acts of violence. As for women, they are more vulnerable to the consequences of substance use for metabolic, hormonal, and cerebral reasons. At the same time, they suffer more psychological problems, somatic complications, and exposure to violence. Sociocultural representations may prevent them from expressing their difficulties and delay their entry into care. It is essential to understand these gender differences in order to take action to reduce the prevalence of substance use among men and to facilitate early detection and treatment among women, particularly around the time of pregnancy.
使用精神活性物质对男性的影响比对女性更大,除了使用镇静剂外,男性的患病率高出1.3至2倍。男性也更容易受到事故、伤害和暴力行为的影响。至于女性,由于代谢、激素和大脑方面的原因,她们更容易受到物质使用后果的影响。与此同时,她们遭受更多的心理问题、躯体并发症,并且更容易遭受暴力。社会文化观念可能会阻碍她们表达自己的困难,并延误她们接受治疗。了解这些性别差异对于采取行动降低男性物质使用的患病率以及促进女性的早期发现和治疗至关重要,尤其是在怀孕前后。